Mobile ECMO in COVID-19 patient: case report
- PDF / 871,941 Bytes
- 6 Pages / 595.276 x 790.866 pts Page_size
- 19 Downloads / 148 Views
CASE REPORT Artificial Lung / ECMO
Mobile ECMO in COVID‑19 patient: case report Martínez Daniela1,2 · Salech Felipe3,4 · Sint Jan Van Nicolette5,6,7 · Regueira Tomás5 · Villalabeitia Eli6,7 · Rufs Jorge7,8 · Fajardo Christian6,7 · Castillo Roberto8 · Iñiguez Jose9 · Durán Luisa4 · Díaz Rodrigo7,8 Received: 28 May 2020 / Accepted: 4 September 2020 © The Japanese Society for Artificial Organs 2020
Abstract At July 25, 2020, WHO had recorded more than 16.1 million confirmed COVID-19 cases, 1% of them developed critical illness. These patients can experience rapid progression to profound hypoxemia and severe acute respiratory distress syndrome (ARDS). Some patients, despite receiving lung-protective ventilation and maximal medical therapy, develop refractory hypoxemia, rendering candidates for extracorporeal membrane oxygenation (ECMO) support. Centers with experience in this technique are available only in a few reference hospitals and some patients are too ill to be transferred with conventional mechanical ventilation so they need mobile ECMO (interhospital transport under ECMO). Here we report the first interhospital extracorporeal membrane oxygenation transport of a COVID-19 patient in Chile, showing that it is feasible and safe to transfer a COVID-19 patient under ECMO support if a mobile ECMO program is correctly implemented and the particularities of protective measures are properly taken. Keywords COVID-19 · ECMO · Mobile ECMO · ARDS · Personal protective equipment
Introduction
* Díaz Rodrigo [email protected] 1
Unidad de Infectología Pediátrica, Hospital San Borja Arriarán, Santiago, Chile
2
Centro de Pacientes Críticos Pediátricos, Clínica Las Condes, Las Condes, Chile
3
Centro de Investigación Clínica Avanzada, Hospital Clínico Universidad de Chile, Independencia, Chile
4
Departamento de Medicina Interna, Clínica Las Condes, Las Condes, Chile
5
Centro de Pacientes Críticos, Clínica Las Condes, Las Condes, Chile
6
Departamento de Cirugía Cardiovascular, Clínica Las Condes, Las Condes, Chile
7
Unidad ECMO, Clínica Las Condes, Las Condes, Chile
8
ECMO Unit, Departamento de Anestesia, Clínica Las Condes, Estoril 450, Las Condes, Santiago, Chile
9
Servicio de Urgencias, Hospital Clínico Magallanes, Punta Arenas, Chile
On December 2019, an outbreak of unexplained pneumonia occurred in Wuhan, China. On January 7, 2020, the causative pathogen was identified as a novel coronavirus, currently named SARS-CoV-2 [1]. The illness caused by this virus—COVID-19—spread swiftly around the globe, and on March 11, 2020, The World Health Organization (WHO) declared COVID-19 as a pandemic [2]. In most patients, the illness produce mild to moderate symptoms but approximately 15% progress to severe pneumonia, about 1% of patients experience progression that can quickly progress to profound hypoxemia and/or ARDS [3]. As of June 25, 2020, more than 16.1 million cases of COVID-19 have been confirmed, with 645,752 deaths. Currently, there are no specific approved treatment, nor a vaccine is available, and su
Data Loading...
